rs748762835

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_205545.3(LYPD2):​c.184C>A​(p.Pro62Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000222 in 1,578,860 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000024 ( 0 hom. )

Consequence

LYPD2
NM_205545.3 missense

Scores

2
10
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.46

Publications

0 publications found
Variant links:
Genes affected
LYPD2 (HGNC:25215): (LY6/PLAUR domain containing 2) Predicted to be located in extracellular region and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LYPD2NM_205545.3 linkc.184C>A p.Pro62Thr missense_variant Exon 3 of 3 ENST00000359228.4 NP_991108.1 Q6UXB3F1T0L0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LYPD2ENST00000359228.4 linkc.184C>A p.Pro62Thr missense_variant Exon 3 of 3 1 NM_205545.3 ENSP00000352163.3 Q6UXB3
ENSG00000253196ENST00000839249.1 linkn.448+11993G>T intron_variant Intron 1 of 2
ENSG00000253196ENST00000839250.1 linkn.296-8576G>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152218
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000238
AC:
34
AN:
1426642
Hom.:
0
Cov.:
33
AF XY:
0.0000184
AC XY:
13
AN XY:
706304
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32664
American (AMR)
AF:
0.00
AC:
0
AN:
39766
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37670
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81204
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50800
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.0000302
AC:
33
AN:
1094202
Other (OTH)
AF:
0.0000169
AC:
1
AN:
59142
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152218
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
74372
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41460
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 17, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.184C>A (p.P62T) alteration is located in exon 3 (coding exon 3) of the LYPD2 gene. This alteration results from a C to A substitution at nucleotide position 184, causing the proline (P) at amino acid position 62 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.41
BayesDel_addAF
Uncertain
0.052
T
BayesDel_noAF
Benign
-0.16
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.16
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.80
T
M_CAP
Benign
0.037
D
MetaRNN
Uncertain
0.46
T
MetaSVM
Uncertain
-0.012
T
MutationAssessor
Pathogenic
3.1
M
PhyloP100
2.5
PrimateAI
Benign
0.42
T
PROVEAN
Pathogenic
-5.2
D
REVEL
Uncertain
0.47
Sift
Benign
0.033
D
Sift4G
Uncertain
0.028
D
Polyphen
1.0
D
Vest4
0.21
MutPred
0.71
Gain of sheet (P = 0.039);
MVP
0.61
MPC
0.70
ClinPred
0.99
D
GERP RS
3.4
Varity_R
0.35
gMVP
0.93
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs748762835; hg19: chr8-143831895; API